CCL2 and neoplasm: Sanford et al. found that an increased ratio of inflammatory monocytes in the blood versus the bone marrow is a novel predictor of decreased pancreatic cancer patient survival following tumor resection, and patients with high CCL2 expression/low CD8 T cell infiltrate have significantly decreased survival [39].